ECHDC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.790500E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.014000E-02
Normal-vs-Stage2
4.012100E-04
Normal-vs-Stage3
7.940300E-02
Normal-vs-Stage4
3.155500E-03
Stage1-vs-Stage2
9.822600E-01
Stage1-vs-Stage3
9.831400E-01
Stage1-vs-Stage4
8.815000E-01
Stage2-vs-Stage3
9.545400E-01
Stage2-vs-Stage4
8.414600E-01
Stage3-vs-Stage4
8.769000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.578100E-04
Normal-vs-AfricanAmerican
7.626200E-02
Normal-vs-Asian
8.343100E-03
Caucasian-vs-AfricanAmerican
1.929710E-02
Caucasian-vs-Asian
9.631000E-01
AfricanAmerican-vs-Asian
8.979700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.550850E-04
Normal-vs-Female
1.604970E-03
Male-vs-Female
5.158300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.314330E-02
Normal-vs-Age(41-60Yrs)
1.016070E-03
Normal-vs-Age(61-80Yrs)
3.188700E-04
Normal-vs-Age(81-100Yrs)
1.422170E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.039600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.369400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.426600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.707230E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.261400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.713630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.209400E-04
Normal-vs-Daily Drinker
2.845300E-04
Normal-vs-Weekly Drinker
6.631800E-04
Normal-vs-Occasional Drinker
2.838200E-04
Normal-vs-Social Drinker
7.828300E-04
Non Drinker-vs-Daily Drinker
1.238600E-01
Non Drinker-vs-Weekly Drinker
5.753800E-01
Non Drinker-vs-Occasional Drinker
9.078400E-01
Non Drinker-vs-Social Drinker
5.579400E-01
Daily Drinker-vs-Weekly Drinker
4.295800E-01
Daily Drinker-vs-Occasional Drinker
1.762360E-01
Daily Drinker-vs-Social Drinker
4.359000E-01
Weekly Drinker-vs-Occasional Drinker
6.404400E-01
Weekly Drinker-vs-Social Drinker
9.862000E-01
Occasional Drinker-vs-Social Drinker
6.279800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.113400E-01
Normal-vs-Grade 2
8.530400E-01
Normal-vs-Grade 3
8.917400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.379800E-01
Grade 1-vs-Grade 3
9.568200E-01
Grade 1-vs-Grade 4
7.113400E-01
Grade 2-vs-Grade 3
4.267200E-01
Grade 2-vs-Grade 4
8.530400E-01
Grade 3-vs-Grade 4
8.917400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.034190E-04
Normal-vs-NonDiabetic
2.037700E-04
Diabetic-vs-NonDiabetic
3.305400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.408200E-04
Normal-vs-NoPancreatitis
2.192300E-04
Pancreatitis-vs-NoPancreatitis
4.489800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.282100E-03
Normal-vs-N1
2.643400E-04
N0-vs-N1
8.326200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.401200E-04
Normal-vs-TP53-NonMutant
6.518600E-03
TP53-Mutant-vs-TP53-NonMutant
3.238400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
